OpenURL Connection Search

Select item for more details and to access through your institution.

Interleukin-6 haplotypes and the response to therapy of chronic hepatitis C virus infection.
Published in:
Genes & Immunity, 2009, v. 10, n. 4, p. 365, doi. 10.1038/gene.2009.26
By:
- Yee, L. J.;
- Im, K.;
- Borg, B.;
- Yang, H.;
- Liang, T. J.;
- Study, Virahep-C
Publication type:
Article
Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection.
Published in:
Genes & Immunity, 2008, v. 9, n. 4, p. 328, doi. 10.1038/gene.2008.21
By:
- Rhodes, S. L.;
- Erlich, H.;
- Im, K. A.;
- Wang, J.;
- Li, J.;
- Bugawan, T.;
- Jeffers, L.;
- Tong, X.;
- Su, X.;
- Rosen, H. R.;
- Yee, L. J.;
- Liang, T. J.;
- Yang, H.
Publication type:
Article
Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection.
Published in:
Genes & Immunity, 2004, v. 5, n. 3, p. 183, doi. 10.1038/sj.gene.6364054
By:
- Yee, L. J.;
- Knapp, S.;
- Burgner, D.;
- Hennig, B. J. W.;
- Frodsham, A. J.;
- Wright, M.;
- Thomas, H. C.;
- Hill, A V. S.;
- Thursz, M. R.
Publication type:
Article
Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection.
Published in:
Genes & Immunity, 2000, v. 1, n. 6, p. 386, doi. 10.1038/sj.gene.6363696
By:
- Yee, L J;
- Tang, J;
- Herrera, J;
- Kaslow, R A;
- van Leeuwen, D J
Publication type:
Article
Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance.
Published in:
2001
By:
- Yee, Leland J.;
- Weiss, Heidi L.;
- Langner, Rebecca G.;
- Herrera, Jorge;
- Kaslow, Richard A.;
- Van Leeuwen, Dirk J.;
- Yee, L J;
- Weiss, H L;
- Langner, R G;
- Herrera, J;
- Kaslow, R A;
- van Leeuwen, D J
Publication type:
journal article
Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.
Published in:
Alimentary Pharmacology & Therapeutics, 2016, v. 44, n. 9, p. 957, doi. 10.1111/apt.13779
By:
- Marcellin, P.;
- Ahn, S. H.;
- Chuang, W.‐L.;
- Hui, A. J.;
- Tabak, F.;
- Mehta, R.;
- Petersen, J.;
- Lee, C.‐M.;
- Ma, X.;
- Caruntu, F. A.;
- Tak, W. Y.;
- Elkhashab, M.;
- Lin, L.;
- Wu, G.;
- Martins, E. B;
- Charuworn, P.;
- Yee, L. J.;
- Lim, S. G.;
- Foster, G. R.;
- Fung, S.
Publication type:
Article
Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort.
Published in:
Journal of Viral Hepatitis, 2011, v. 18, n. 4, p. e144, doi. 10.1111/j.1365-2893.2010.01394.x
By:
- Ramcharran, D.;
- Wahed, A. S.;
- Conjeevaram, H. S.;
- Evans, R. W.;
- Wang, T.;
- Belle, S. H.;
- Yee, L. J.
Publication type:
Article

Found: 7

Interleukin-6 haplotypes and the response to therapy of chronic hepatitis C virus infection.

Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection.

Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection.

Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection.

Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance.

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.

Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort.